At Astellas, we are committed to discovering and developing innovative therapies that address unmet needs.
For an overview of Astellas’ global R&D pipeline, please visit Astellas Pharma Inc.’s website.
Astellas has research laboratories in the United States, the Netherlands and Japan. These facilities explore chemical compounds, natural substances and proteins to find new drug treatments. Astellas uses technologies such as genomics, bioinformatics, radiation analysis, computer analysis and image analysis to develop pharmaceuticals that are effective for patients and competitive on the global market. All products are fully tested for safety, tolerability and efficacy through clinical studies carried out in Japan, North America and Europe.
To stay ahead in research & development, Astellas frequently collaborates with promising external research institutes and ventures.
Astellas employs the highest legal and ethical standards when conducting exploratory research involving humans or animals.
Our Canadian research team actively participates in global multicentre clinical studies conducted at university medical centres, hospitals and clinics across the country. Astellas also supports extensive Phase 4 clinical trial research programs with Canadian investigators from all parts of the country in order to address novel and important questions related to Astellas therapeutic areas.